Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefasleeve: Cefazolin Pharmacokinetics in Bariatric Surgery
NCT01537380Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Mar 2012
- Primary completion
- Apr 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefazolin in surgical site infection (SSI), sponsored by CHU de Nantes. Primary endpoint: Tissue concentration of cefazolin in the superficial subcutaneous fat. Started Mar 2012; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT01537380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537380.